Clinical outcomes of conversion surgery following neoadjuvant chemoimmunotherapy in potentially resectable stage IIIA/IIIB non-small cell lung

Abstract Neoadjuvant chemoimmunotherapy has been successfully used in patients with resectable non-small-cell lung cancer (NSCLC). However, its application to potentially resectable IIIA/IIIB NSCLC remains controversial. This retrospective study aims to evaluate the efficacy and safety of neoadjuvan...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Yana Qi, Yulan Sun, Yanran Hu, Hui Zhu, Hongbo Guo
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Nature Portfolio 2025-05-01
Edice:	Scientific Reports
Témata:	Non-small-cell lung cancer Potentially resectable Neoadjuvant chemoimmunotherapy Conversion surgery
On-line přístup:	https://doi.org/10.1038/s41598-025-99571-y
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!